Leaflet RAGWIZAX 12 SQ-AMB sublingual lyophilisate


Indicated for: ragweed-induced allergic rhinitis

Route of administration: sublingual

Substance: standardized allergenic extract of ambrosia pollen (allergenic extract)

ATC: V01AA10 (Various | Allergens | Allergen extracts)

Standardized ragweed pollen allergen extract is a medication used in specific immunotherapy for treating allergies to ragweed pollen. This treatment helps reduce the body's sensitivity to pollen, alleviating symptoms such as sneezing, runny nose, itchy eyes, and breathing difficulties that occur during the pollen season.

The extract is administered as drops or sublingual tablets, following a protocol established by an allergist. Treatment usually starts with small doses that gradually increase, allowing the immune system to become accustomed to the allergen and reducing the risk of adverse reactions.

Side effects may include local reactions in the mouth or throat, such as itching, swelling, or irritation. In rare cases, severe allergic reactions can occur, which is why the treatment must be carried out under strict medical supervision, especially at the beginning.

Standardized ragweed pollen allergen extract is an effective solution for patients with severe allergies to this type of pollen, helping to improve quality of life and reduce the need for symptomatic medications in the long term.

General data about RAGWIZAX 12 SQ-AMB

  • Substance: standardized allergenic extract of ambrosia pollen
  • Date of last drug list: 01-05-2026
  • Commercial code: W64895001
  • Pharmaceutical form: sublingual lyophilisate
  • Quantity: 30
  • Product type: original
  • Price: 1292.28 RON
  • Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

  • Manufacturer: ALK-ABELLO S.A. - SPANIA
  • Holder: ALK-ABELLO A/S - DANEMARCA
  • Number: 14748/2022/01
  • Shelf life: 5 years